Grace Therapeutics, Inc.
GRCE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001444192
In the last 90 days, Grace Therapeutics, Inc. insiders filed 4 open-market purchases and 0 sales; 33 institutions reported holding it in 13F filings for Q2 2026, worth $8.74M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Grace Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- +1 vs. Q2 2023
- Shares held
- 558.3K
- +493.4K (+760.0%) vs. Q2 2023Converted for a 1-for-6 split
- Total value
- $1.55M
- +$1.35M (+660.3%) vs. Q2 2023
- New holders
- 6
- 1 more added
- Sold out
- 5
- 2 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GRCE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $8.74M |
| Q1 2026 | 34 | $19.7M |
| Q4 2025 | 23 | $15.0M |
| Q3 2025 | 20 | $11.0M |
| Q2 2025 | 20 | $11.3M |
| Q1 2025 | 17 | $9.17M |
| Q4 2024 | 15 | $7.84M |
| Q3 2024 | 12 | $6.36M |
| Q2 2024 | 12 | $6.30M |
| Q1 2024 | 10 | $4.34M |
| Q4 2023 | 9 | $1.65M |
| Q3 2023 | 12 | $1.55M |
| Q2 2023 | 11 | $204.2K |
| Q1 2023 | 12 | $189.6K |
| Q4 2022 | 9 | $24.8K |
| Q3 2022 | 9 | $53.1K |
| Q2 2022 | 10 | $108.2K |
| Q1 2022 | 9 | $183.7K |
| Q4 2021 | 13 | $248.8K |
| Q3 2021 | 14 | $356.5K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Grace Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 494,698 | $1.38M | 0.00% | +494,698 | New |
| TD Private Client Wealth LLC | 40,132 | $110.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-6 split |
| Coastal Bridge Advisors, LLC | 10,000 | $27.8K | 0.01% | +10,000 | New |
| UBS Group AG | 4,712 | $13.1K | 0.00% | +4,712 | New |
| JPMorgan Chase & Co | 3,358 | $9.20K | 0.00% | +3,358 | New |
| National Bank of Canada | 2,901 | $8.13K | 0.00% | −169−5.5% | ReducedConverted for a 1-for-6 split |
| Morgan Stanley | 1,882 | $5.24K | 0.00% | 00.0% | UnchangedConverted for a 1-for-6 split |
| Royal Bank of Canada | 584 | $2.00K | 0.00% | 00.0% | UnchangedConverted for a 1-for-6 split |
| Federation des caisses Desjardins du Quebec | 28 | $78 | 0.00% | −2−6.1% | ReducedConverted for a 1-for-6 split |
| Impact Partnership Wealth, LLC | 10 | $28 | 0.00% | +10 | New |
| TD Waterhouse Canada Inc. | 1 | $4 | 0.00% | +0+50.0% | AddedConverted for a 1-for-6 split |
| NBC Securities, Inc. | 2 | $0 | 0.00% | +2 | New |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −11,267−100.0% | Sold outConverted for a 1-for-6 split |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −3,058−100.0% | Sold outConverted for a 1-for-6 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −2,515−100.0% | Sold outConverted for a 1-for-6 split |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −2,369−100.0% | Sold outConverted for a 1-for-6 split |
| ICA Group Wealth Management, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold outConverted for a 1-for-6 split |